SCLERO.ORG
Search
Scleroderma Newsroom
ISN News Manager: Jo Frowde
Autoimmune
Media Stories
Scleroderma
ISN/Website
Media News Archive
We maintain news archives for the most recent 3 years.
2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2020 - 2019 - 2018 - 2017

December 2020 Media News

Analysis: Can first COVID-19 vaccines bring herd immunity? Experts have doubts. Governments and officials are voicing hopes that COVID-19 vaccines could bring “herd immunity”, with some calculating that immunising just two-thirds of a population could halt the pandemic disease and help protect whole communities or nations. Reuters Health, 11/18/2020.

No firm evidence of food trade spreading coronavirus: Food and Agriculture Organization of the United Nations (FAO). There is no significant evidence of coronavirus being spread through food trade and such reports “need to be minimised”. Reuters Health, 11/18/2020.

Immunity to the Coronavirus May Last Years, New Data Hint Blood samples from recovered patients suggest a powerful, long-lasting immune response, researchers reported. New York Times, 11/17/2020.

Does an Autoimmune Disorder Affect My Covid-19 Risks? Patients with conditions like lupus and rheumatoid arthritis, who may take immune suppressing drugs, do not appear to be at greatly increased risk from coronavirus. New York Times, 11/18/2020. (Also see Immunosuppressants)

The Greatest Gift to Loved Ones This Covid Winter? Don’t Infect Others. People are losing respect for the virus and letting their guard down, which is a bad idea. New York Times, 11/16/2020.

Immunity to the Coronavirus May Last Years, New Data Hint. Blood samples from recovered patients suggest a powerful, long-lasting immune response, researchers reported. New York Times, 11/17/2020.

How the pandemic is impacting kids’ mental health. Many kids are feeling isolated, afraid and overwhelmed because of the coronavirus pandemic, and parents are struggling with how to help. NBC Health News, 11/16/2020.

The Most Promising Alzheimer’s Drug in Years Took a Thrashing From an FDA Advisory Committee. People receiving aducanumab did no better than people getting placebo when it came to amyloid in their brains or their performance on cognitive tests. Time Healthland, 11/10/2020.

Lockdown loneliness reaches record levels. The week after the clocks went back saw Britain's highest levels of acute loneliness in the pandemic, Office for National Statistics figures suggest. BBC Health News, 11/18/2020.

Have coronavirus lockdowns made us more forgetful? California scientists launch study to test whether isolation and anxiety while staying home have impaired our memories. Mail Online, 11/17/2020. (Also see Anxiety and Attitude)

Go to Scleroderma Media News: November 2020
 

We have the world's best supporters! See ISN News.

 

SCLERO.ORG is the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses. We are a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA
Email [email protected]. Disclaimer. Privacy Policy.
 

The most important thing in the world to know about scleroderma is sclero.org!